Gujarat Themis Biosyn Ltd

BSE :506879 NSE :- Sector : Pharmac..
251.50
Change: 39.30(18.52%)
52 week Low
192.35
52 week High
390.00
Day low
206.20
Day high
254.60
Prev Close
212.20
Open
210.10
6M return
-28.40%
1Y return
10.34%
MCap(Rs. in Cr.)
2,312.24
Total Volume
3,99,798
Face Value : 1
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
43.93
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
4.83
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
12.27
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
49.05%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.31

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales
47.86%

Sales Industry Avg
2.98%

PAT
35.63%

PAT Industry Avg
-38.30%

Dec 2024
( in Cr.)
Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
FY 2024
( in Cr.)
Sales39.5234.7238.8342.01169.82
Gross Profit18.9615.6319.0121.8782.87
Operating Profit00000
Profit Before Tax17.4114.1917.8120.8679.33
Tax4.443.624.574.9720.17
Profit After Tax12.9710.5713.2415.8959.16
No data available
20%
2023
75%
25%
2024 2025
2026


Relative to Sensex rtn in 3 year
1,267.52%

Relative to Nifty rtn in 3 year
1,207.62%



1 Year (%)2 Year (%)3 Year (%)
Guj. Themis Bio.10187428
Bse Sensex42531
Nifty 5042933
Bse Healthcare128168

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Guj. Themis Bio.
251.50
Change: 39.30 (18.52%)
1 Year return
10.34%
Risk (Std Dev)
0.13%
PE Ratio
43.93
MCap( in Cr.)
2,312.24
Emcure Pharma
996.00
Change: 996.00 (0.00%)
1 Year return
0.00%
Risk (Std Dev)
-
PE Ratio
30.79489
MCap( in Cr.)
18,713.97
Sai Life
668.10
Change: -2.80 (-0.42%)
1 Year return
-12.70%
Risk (Std Dev)
0.00%
PE Ratio
101.19155
MCap( in Cr.)
13,954.02
Blue Jet Health
788.95
Change: 37.30 (4.96%)
1 Year return
127.76%
Risk (Std Dev)
0.11%
PE Ratio
55.55
MCap( in Cr.)
13,038.53
Sanofi Consumer
4,780.00
Change: 83.20 (1.77%)
1 Year return
1.64%
Risk (Std Dev)
0.03%
PE Ratio
NM
MCap( in Cr.)
10,817.02
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 1,10,340.90 with a Gain of 10.34%

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

D
S
2023
D
D
B
2024
2025

News

Stay tuned to the latest developments and happenings in the company.

Gujarat Themis Biosyn standalone net profit declines 0.31% in the December 2024 quarter

Net profit of Gujarat Themis Biosyn declined 0.31% to Rs 12.97 crore in the quarter ended December 2024 as against Rs 13.01 crore during the previous ....

14 Feb 2025 14:45

Gujarat Themis Biosyn to convene board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live N....

11 Feb 2025 10:53

Board approved merger of Gujarat Themis Biosyn with Themis Medicare

The Board of Directors of Gujarat Themis Biosyn (GTBL) and Themis Medicare (TML) have approved a Scheme of Amalgamation of Gujarat Themis Biosyn wi....

19 Nov 2024 09:10

Gujarat Themis Biosyn standalone net profit declines 15.71% in the September 2024 quarter

Net profit of Gujarat Themis Biosyn declined 15.71% to Rs 10.57 crore in the quarter ended September 2024 as against Rs 12.54 crore during the previou....

25 Oct 2024 18:28

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live Ne....

19 Oct 2024 09:25

Gujarat Themis Biosyn standalone net profit declines 25.28% in the June 2024 quarter

Net profit of Gujarat Themis Biosyn declined 25.28% to Rs 13.24 crore in the quarter ended June 2024 as against Rs 17.72 crore during the previous qua....

26 Jul 2024 14:49

View More
Subscribe for our
newsletter
Open Account Now